Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 May;2(5):561-6.
doi: 10.1038/nm0596-561.

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

B J Druker  1 , S Tamura, E Buchdunger, S Ohno, G M Segal, S Fanning, J Zimmermann, N B Lydon
Affiliations

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

B J Druker et al. Nat Med. 1996 May.

Abstract

The bcr-abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease. A compound, designed to inhibit the Abl protein tyrosine kinase, was evaluated for its effects on cells containing the Bcr-Abl fusion protein. Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compound. In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the number of bcr-abl colonies formed but no inhibition of normal colony formation. This compound may be useful in the treatment of bcr-abl-positive leukemias.

PubMed Disclaimer

Publication types

MeSH terms